{"id":4773,"date":"2025-01-23T06:21:22","date_gmt":"2025-01-22T20:21:22","guid":{"rendered":"\/eu-uk\/?p=4773"},"modified":"2025-01-23T06:21:22","modified_gmt":"2025-01-22T20:21:22","slug":"stockhead-orthocell-soars-14-after-crushing-early-sales-growth-for-remplir","status":"publish","type":"post","link":"\/eu-uk\/blog\/2025\/01\/23\/stockhead-orthocell-soars-14-after-crushing-early-sales-growth-for-remplir\/","title":{"rendered":"Stockhead | Orthocell soars 14% after crushing early sales growth for Remplir"},"content":{"rendered":"<p class=\"whitespace-pre-wrap break-words\">Orthocell&#8217;s plans to broaden its commercial footprint in existing and new markets drove the company&#8217;s share price up 13.8% this week, according to a special report in Stockhead.<\/p>\n<p class=\"whitespace-pre-wrap break-words\">The rise followed news of Orthocell plans to accelerate efforts to enter several key markets across CY25 including Thailand, Canada, the UK, Brazil and European Union, building on a third quarter of record revenue.<\/p>\n<p>Here&#8217;s an excerpt:<br \/>\n&#8220;Perth-headquartered Orthocell was a hero of the ASX healthcare sector in 2024. The company is up more than 265% in the past year and ~20% over the past month. Orthocell sits among the top five performing ASX healthcare stocks of the past year.&#8221;<\/p>\n<p><a href=\"https:\/\/stockhead.com.au\/health\/orthocell-soars-14-after-crushing-early-sales-growth-for-remplir\/\">Click to read the full article.<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Orthocell&#8217;s plans to broaden its commercial footprint in existing and new markets drove the company&#8217;s share price up 13.8% this week, according to a special report in Stockhead.<\/p>\n","protected":false},"author":2,"featured_media":4751,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[3],"tags":[],"class_list":["post-4773","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-media"],"aioseo_notices":[],"_links":{"self":[{"href":"\/eu-uk\/wp-json\/wp\/v2\/posts\/4773","targetHints":{"allow":["GET"]}}],"collection":[{"href":"\/eu-uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"\/eu-uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"\/eu-uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"\/eu-uk\/wp-json\/wp\/v2\/comments?post=4773"}],"version-history":[{"count":1,"href":"\/eu-uk\/wp-json\/wp\/v2\/posts\/4773\/revisions"}],"predecessor-version":[{"id":4774,"href":"\/eu-uk\/wp-json\/wp\/v2\/posts\/4773\/revisions\/4774"}],"wp:featuredmedia":[{"embeddable":true,"href":"\/eu-uk\/wp-json\/wp\/v2\/media\/4751"}],"wp:attachment":[{"href":"\/eu-uk\/wp-json\/wp\/v2\/media?parent=4773"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"\/eu-uk\/wp-json\/wp\/v2\/categories?post=4773"},{"taxonomy":"post_tag","embeddable":true,"href":"\/eu-uk\/wp-json\/wp\/v2\/tags?post=4773"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}